NASDAQ:CORT - Nasdaq - US2183521028 - Common Stock - Currency: USD
We assign a fundamental rating of 7 out of 10 to CORT. CORT was compared to 194 industry peers in the Pharmaceuticals industry. CORT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CORT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make CORT suitable for growth and quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 15.83% | ||
ROE | 19.61% | ||
ROIC | 13.61% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 16.17% | ||
PM (TTM) | 19.55% | ||
GM | 98.43% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 30.22 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 3.07 | ||
Quick Ratio | 2.96 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 61.09 | ||
Fwd PE | 26.12 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 42.41 | ||
EV/EBITDA | 61.79 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
70.86
-2.24 (-3.06%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 61.09 | ||
Fwd PE | 26.12 | ||
P/S | 10.96 | ||
P/FCF | 42.41 | ||
P/OCF | 41.87 | ||
P/B | 11 | ||
P/tB | 11 | ||
EV/EBITDA | 61.79 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 15.83% | ||
ROE | 19.61% | ||
ROCE | 15.76% | ||
ROIC | 13.61% | ||
ROICexc | 25.27% | ||
ROICexgc | 25.27% | ||
OM | 16.17% | ||
PM (TTM) | 19.55% | ||
GM | 98.43% | ||
FCFM | 25.85% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | 0 | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | 250 | ||
Cash Conversion | 159.44% | ||
Profit Quality | 132.22% | ||
Current Ratio | 3.07 | ||
Quick Ratio | 2.96 | ||
Altman-Z | 30.22 |